Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Idioma
Intervalo de año de publicación
1.
Vestn Otorinolaringol ; 86(5): 114-118, 2021.
Artículo en Ruso | MEDLINE | ID: mdl-34783484

RESUMEN

Nasal septum perforations complete elimination is possible only with surgical treatment. However, most of perforation symptoms and clinical manifestations can be reduced with conservative treatments, thus improving the patient's quality of life. This article presents a short review of publications and our own clinical examples of nasal septum perforation conservative treatment methods in children and adults. Palliative methods and preparing for surgical closure are described.


Asunto(s)
Perforación del Tabique Nasal , Adulto , Niño , Tratamiento Conservador , Humanos , Perforación del Tabique Nasal/diagnóstico , Perforación del Tabique Nasal/etiología , Perforación del Tabique Nasal/cirugía , Tabique Nasal/cirugía , Plásticos , Calidad de Vida
2.
Antibiot Khimioter ; 46(2): 26-32, 2001.
Artículo en Ruso | MEDLINE | ID: mdl-11544748

RESUMEN

It is postulated that P. aeruginosa in monoculture or in association with Staphylococcus aureus keeps its leading position in chronic bacterial inflammatory broncho-pulmonary processes in children with cystic fibrosis. Antibiotic resistant strains of Burkholderia cepacia, Stenotrophomonas maltophila, Alcaligenes xylosoxidans were revealed (7.1% of the strains). P. aeruginosa strains were susceptible to aminoglycosides, ciprofloxacin, and polymixin B. Susceptibility of smooth and mucoid forms of P. aeruginosa to ceftazidime stayed at the level of 49.6-57.1%. Such microbial associations as P. aeruginosa sm. + S. aureus, P. aeruginosa sm. + P. aeruginosa muc. + S. aureus were mainly susceptible to ciprofloxacin, aminoglycosides and resistant to ceftasidime. Meropenem, cefepim and ciprofloxacin are highly effective antibiotics for the treatment of broncho-pulmonary processes exacerbations at children with chronic P. aeruginosa cystic fibrosis. Intravenous use of antibiotics out of hospital for the treatment of the children with cystic fibrosis is clinically effective, and is economically and psychologically reasonable. It should be used more widely in medical practice.


Asunto(s)
Antibacterianos/uso terapéutico , Fibrosis Quística/complicaciones , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Antibacterianos/efectos adversos , Antibacterianos/farmacología , Bronquios/metabolismo , Bronquios/microbiología , Niño , Farmacorresistencia Microbiana , Humanos , Infusiones Intravenosas , Pacientes Ambulatorios , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/efectos de los fármacos , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...